Encell Co. Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It provides customized pharmaceutical development services, from early development stage to approval stage. The company was founded in February 2018 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company